Worldwide Bioprocess Validation Market valuation to cross USD 541 million by 2027

April 28, 2021


According to the research report titled ‘Bioprocess Validation Market by Test Type (Extractables and Leachable, Integrity Testing, Microbiological Testing), by Process Component (Filter elements, Media containers and bags, Freezing and thawing process bags, Mixing systems, Bioreactors ), by End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Development & Manufacturing Organizations, Others) and Regional Forecasts - 2019 to 2027’, available with Market Study Report LLC, global bioprocess validation market was evaluated at USD 180 million in 2019 and is speculated to reach USD 541.82 million by 2027, growing at a yearly rate of 14.6% throughout.
 

Emphasis on improving the feasibility of operations & processes in pharmaceutical & biopharmaceutical sector is the key factor boosting the bioprocess validation market growth. Moreover, strict standards & regulations for validity & quality of bioprocesses, and rising production of biopharmaceuticals are contributing to the market share.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2956033/
 

For the uninitiated, bioprocess validation is the analysis of data collected throughout the production and design process of a desirable product to study the parameters, and ensure that quality of product meets the predetermined standards.
 

Leading companies have made strategic decisions like product launches, partnerships etc.  which help them to garner revenue and also proliferate the industry. Citing an example, Toxikon Corp. partnered with SG Laboratory Ltd. in March 2017 to determine drug integrity in the entire life cycle using analytical and extractable testing service portfolio.
 

Likewise, the Merck Group stated in January 2020 that it will invest USD 292.3 million to build a biotech-based unit in Switzerland. The main reason behind this decision was interest in combining biologics development and creation.
 

While entry of new drugs in the biopharmaceuticals will facilitate market expansion, rising demand for these products is connected to high risk of drug adulteration which will hamper bioprocess validation industry outlook.
 

Speaking of regional outlook, Asia Pacific market is projected to showcase lucrative growth over 2020-2027, owing to rising preference for outsourcing bioprocess validation, increasing life science research specific to biologics, and growing investments by biotechnology & pharmaceutical companies. Furthermore, initiatives by government to boost growth of pharmaceutical & biotechnology sector in various countries will stimulate APAC market scenario.
 

Key players influencing bioprocess validation market trends are Sartorius AG, Thermo Fisher Scientific, Eurofins Scientific SE, Toxikon Corporation, Pall Corporation, D.O.C. SRL, SGS S.A., Hangzhou Cobetter Filtration Equipment Co. Ltd., The Merck Group, and Meissner Filtration Products Inc.

Chat with us